Related Experiment Video
Updated: Jun 16, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Deep Diving Into the Cardiovascular Health Paradox: A Journey Towards Personalized Prevention.
Bamba Gaye1,2, Nabila Bouatia Naji2, Mario Sims3
1Alliance for Medical Research in Africa (AMedRA), Department of Medical Physiology, Cheikh Anta Diop University, Dakar, Senegal.
The cardiovascular health paradox, where optimal lifestyle scores don't always prevent heart disease, needs a new approach. Personalized prevention using novel biomarkers and genetic factors can improve cardiovascular disease outcomes.
Area of Science:
- Cardiovascular Health
- Preventive Cardiology
- Personalized Medicine
Background:
- The Life's Simple 7 (LS7) score promotes cardiovascular health (CVH), but some individuals with optimal LS7 develop cardiovascular disease (CVD), while others with poor CVH do not—this is the "CVH paradox."
- Current risk factor assessments are often suboptimal for predicting individual outcomes.
Purpose of the Study:
- To explore the pathways explaining the CVH paradox.
- To propose refined CVH assessment strategies for personalized prevention.
Main Methods:
- Examined methodological aspects including misclassification bias in self-reported lifestyle factors (smoking, physical activity, diet).
- Considered the impact of cumulative exposure to risk factors over a lifetime.
- Proposed incorporating novel elements for refined CVH assessment: subclinical vascular disease markers, metabolic biomarkers, emerging risk factors, polygenic risk scores (PRS), epigenetics, and the exposome.
Main Results:
- Addressing the CVH paradox requires a multifaceted approach.
- Reducing misclassification bias and considering cumulative risk exposure are crucial.
- Incorporating novel personalized prevention elements can refine CVH assessment.
Conclusions:
- A holistic, individualized approach to CVH assessment and CVD prevention is essential for reducing cardiovascular outcomes and improving population health.
- Effective implementation requires collaboration among researchers, healthcare providers, policymakers, and communities.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Hypertension and Regulation of Blood Pressure

